Transforming Care for Vitreous Opacities
A groundbreaking, non-surgical solution for vitreous opacities and vitreous degeneration*. Empower your patients with hope and relief through our clinically-backed formula.
Why Recommend Haro Clear?
Take the next step in helping your patients achieve clearer vision and better eye health! Providers already recommend Haro Clear as a non-invasive solution for vitreous floaters.
Evidence-Based Formula
Formulated based on published, peer-reviewed clinical studies.
Ingredients evaluated for associations with vitreous clarity and visual comfort.*
Non-Invasive Approach
A non-surgical option informed by clinical research.
Uses ingredients studied for their role in supporting vitreous health and visual clarity.*
Treatment Timeline
3–6 months is the typical timeframe to evaluate outcomes.
Continued use is recommended to support long-term vitreous health.*
Inside the Eye: Diagnostic Imaging
OCT and B-Scan ultrasound images used by eye care professionals to visualize internal eye structures
OCT Scan
Before: A male diabetic patient (age 58) with Vitreous Hemorrhage (VH) -induced SVOs at the beginning of the study. The dark-red cloud overlapped the retinal fundus.
After: VH-induced SVOs gradually diminished after a three-month mixed fruit enzyme supplement. Vision improved from 20/200 to 20/40.
B-Scan
Before: A female patient (age 55) with one SVO diagnosed by ultrasonography (B-scan) at the beginning of the study.
After: The SVO significantly disappeared after 3 months of treatment with mixed fruit enzymes, as observed in the B-scan evaluation.
Decrease in vitreous opacity areas in over 75% of patients supplemented with Haro Clear formula*
Breaks Down Collagen Fibers
Helps dissolve collagen fibers in the vitreous, resulting in less noticeable floaters and improved vision clarity.*
Alternative to Watchful Waiting
Patients with floaters are often monitored for 6 months before treatment; Haro Clear provides a proactive option.
Clinically Tested Formulation
The blend contains antioxidative and antiglycation micronutrients that have been clinically evaluated.
Survey Says...
How many patients felt unheard?
According to a Haro Health survey, 72% of patients experiencing eye floaters said they sought a second opinion or researched treatment options independently because they felt dismissed or believed their provider lacked the experience or information needed to address vitreous floaters.
Monetization Opportunity
Haro Clear provides clinics and doctors with a lucrative revenue stream, generating on average $20K or more in annual profit per location while offering patients a proven, non-invasive solution for eye floaters and healthy vitreous.
FAQ
What is Haro Clear?
Haro Clear is a specialized dietary supplement formulated to support eye health, particularly targeting symptoms like eye floaters, dry eyes, and general vitreous and retinal health. It includes vitamins, minerals, and antioxidants such as Lutein, Zeaxanthin, Zinc, Bromelain, and Vitamin C.
Who should take Haro Clear?
Haro Clear is recommended for adults experiencing visual discomfort, including eye floaters, dryness, or individuals looking to support their overall eye health and vision clarity. It is particularly beneficial for patients before and after vitreolysis procedures or vitreous detachment, as it supports vitreous health and recovery by promoting collagen structure, hydration, and antioxidant protection within the vitreous and the eye. Ideal candidates also include those in early stages of floater development, individuals looking for non-invasive options to support eye health, and post-procedure patients aiming to maintain improvements and overall ocular integrity.
How do we contact Haro Health for further inquiries or support?
For additional questions, support, or to place a wholesale order, please contact us at providers@harohealth.com
Is Haro Clear manufactured under safe and certified conditions?
Absolutely. Haro Clear is manufactured in Oklahoma, USA adhering strictly to FDA cGMP guidelines (21 CFR Part 111) to ensure product safety, efficacy, and quality.
Can clinics obtain samples for patients?
Yes, we provide limited samples to clinics interested in evaluating Haro Clear for their patients. Please contact us directly to request samples.
Do you provide marketing or informational materials for clinics?
Yes. Clinics that stock Haro Clear receive informational brochures, patient flyers, and, upon request, complimentary pop-up displays to enhance patient education and awareness. Please reach out to us at providers@harohealth.com
What are the wholesale pricing tiers available?
Once your wholesale account is approved, a list of prices will be available to you.
How can clinics and healthcare providers purchase Haro Clear for their patients?
Clinics and healthcare providers can order directly from Haro Health Wholesale account, or through our partner DryEyeRescue.com. Volume discounts are available based on order size.
Can Haro Clear be taken alongside other medications?
While Haro Clear generally doesn't interact negatively with common medications, we recommend that patients consult their healthcare providers, especially if they are on anticoagulant therapy or have specific medical conditions.
Are there any side effects associated with Haro Clear?
Haro Clear is formulated from natural ingredients generally recognized as safe (GRAS). However, patients with known allergies to ingredients such as pineapple (source of bromelain) or other sensitivities should consult their healthcare provider before use.
What is the recommended dosage for Haro Clear?
The standard recommended dosage is 2 capsules daily (one in the morning and one in the evening), preferably with meals.
What is the ICD-10 code for vitreous floaters?
The most commonly used ICD-10 codes associated with vitreous floaters and vitreous opacities fall under the H43 category (Disorders of vitreous body). Commonly referenced codes include:
- H43.39 – Other vitreous opacities
- H43.813 / H43.819 – Vitreous degeneration (eye-specific)
- H43.399 – Unspecified vitreous opacity
Coding selection may vary based on clinical findings, laterality, and documentation.
